New positive donidalorsen data to be presented at 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
– Data continue to demonstrate donidalorsen potential to deliver significant and sustained reductions in HAE attacks up to three years...
